Dudediligence.

Oruka Therapeutics, Inc

ORKANASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$333.6M

13 notices · 3,972,737 sh

Mar 3 to Oct 4

Reported ·

$13.7M

55 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

48 of 55 reported sales carry the 10b5-1 box. Together they are 0.37% of the shares on issue.

PLANNED · FORM 144Mar 3 to Oct 4REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-10-01: LAWRENCE KLEIN, Form 1442026-09-21: Arjun Agarwal, Form 1442026-09-01: LAURA SANDLER, Form 1442026-09-01: LAWRENCE KLEIN, Form 1442026-08-14: PAUL QUINLAN, Form 1442026-07-15: JOANA GONCALVES, Form 1442026-07-13: Arjun Agarwal, Form 1442026-07-01: Fairmount Healthcare Fund II L.P., Form 1442026-06-11: CARL DAMBKOWSKI, Form 1442026-05-21: CARL DAMBKOWSKI, Form 1442026-05-18: ARJUN AGARWAL, Form 1442026-05-01: LAURA SANDLER, Form 1442026-04-15: JOANA GONCALVES, Form 1442025-12-19: Goncalves Joana, sold2026-01-02: Sandler Laura Lee, sold2026-01-15: Goncalves Joana, sold2026-02-17: Goncalves Joana, sold2026-03-02: Sandler Laura Lee, sold2026-03-16: Quinlan Paul T, sold2026-03-16: Goncalves Joana, sold2026-03-16: Sandler Laura Lee, sold2026-03-16: Agarwal Arjun, sold2026-03-16: Klein Lawrence Otto, sold2026-04-15: Goncalves Joana, sold2026-05-01: Sandler Laura Lee, sold2026-05-15: Goncalves Joana, sold2026-05-18: Agarwal Arjun, sold2026-05-21: Dambkowski Carl, sold2026-06-11: Dambkowski Carl, sold2026-06-12: Agarwal Arjun, sold2026-06-15: Quinlan Paul T, sold2026-06-15: Sandler Laura Lee, sold2026-06-15: Klein Lawrence Otto, sold2026-06-15: Goncalves Joana, sold2026-06-22: Agarwal Arjun, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-01LAWRENCE KLEIN, Chief Executive Officer$2,082,250
25,000 shplan 2026-05-14Form 4s on file end Jun 23144 ↗
2026-09-21Arjun Agarwal, Senior Vice President, Finance$50,614
533 shplan 2026-02-11Form 4s on file end Jun 23144 ↗
2026-09-01LAURA SANDLER, Chief Operating Officer$463,100
5,000 shplan 2025-09-19Form 4s on file end Jun 23144 ↗
2026-09-01LAWRENCE KLEIN, Chief Executive Officer$6,946,500
75,000 shplan 2026-05-14Form 4s on file end Jun 23144 ↗
2026-08-14PAUL QUINLAN, General Counsel$7,676,520
71,000 shplan 2026-05-15Form 4s on file end Jun 23144 ↗
2026-07-15JOANA GONCALVES, Chief Medical Officer$1,836,870
21,000 shplan 2025-09-19Form 4s on file end Jun 23144 ↗
2026-07-13Arjun Agarwal, Senior Vice President, Finance$2,481,153
28,588 shplan 2026-02-11Form 4s on file end Jun 23144 ↗
2026-07-01Fairmount Healthcare Fund II L.P., Director, 10% Stockholder$300.0M
3,553,410 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-11CARL DAMBKOWSKI, Director$2,241,050
35,000 shplan 2026-02-19144 ↗
Form 4, 2026-06-12: sold 35,000 at $70.12 Form 4 ↗
2026-05-21CARL DAMBKOWSKI, Director$6,370,350
105,000 shplan 2026-02-19144 ↗
Form 4, 2026-05-22: sold 105,000 at $58.97 Form 4 ↗
2026-05-18ARJUN AGARWAL, Senior Vice President, Finance$1,375,218
22,206 shplan 2026-02-11144 ↗
Form 4, 2026-05-18: sold 10,290 at $59.07 Form 4 ↗
2026-05-01LAURA SANDLER, Chief Operating Officer$684,100
10,000 shplan 2025-09-19144 ↗
Form 4, 2026-05-01: sold 5,000 at $63.88 Form 4 ↗
2026-04-15JOANA GONCALVES, Chief Medical Officer$1,408,260
21,000 shplan 2025-09-19144 ↗
Form 4, 2026-04-15: sold 7,000 at $66.12 Form 4 ↗